skinny.

Latest / Dothan News Today | 2 Min News | The Daily News Now!

First RAS-Targeting Drug Approved for Pancreatic Cancer | Dothan News

FDA just approved a game-changing pill for advanced pancreatic cancer — Rasonque, the first drug designed to directly attack the mutated RAS protein that drives this deadly disease. In trials, it doubled median survival from six to 13 months and slashed death risk by 60% compared to chemo. Already being used by over 2,000 patients through an expanded access program, it’s hailed as a breakthrough — though side effects like rash and nausea are expected. Cost remains unknown, but for patients with few options, this could be life-changing. Listen in comfort:Get a discount on a Soli Pillow…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.